The first description of COX-2 expression in GC goes back to 1997 and many studies reported an increase of its levels in H. pylori-mediated gastritis, suggesting that high COX-2 levels is an early event induced by this bacteria in gastric carcinogenesis (67–74). Here, PTGS2 is linked to gastric cancer.